Just the headlines - in your inbox

Movers and shakers in the pharma and biotech industries stay one step ahead of the competition by subscribing to the pharmaphorum newsletter. You can get a daily download of the top five news stories of the day, a weekly roundup of must-read content, or you can subscribe to be notified of the release of our bi-monthly Deep Dive into an important topic in life sciences.

At pharmaphorum, our coverage spans job functions, keeping you informed about:

  • Research and Development, including key readouts and clinical trials
  • Market Access, including regulatory approvals and setbacks
  • Sales and Marketing, including drug launches and agency news
  • Innovation, including digital health and artificial intelligence
  • Patient stories and patient perspectives

We report the news and add context and analysis, so you can be informed about all aspects of the industry. Our content includes daily news as well as live event coverage, longer features, and multimedia content like podcasts and videos. Sign up today and don't miss another story!

 
* indicates required
























Subscription Options 

By clicking on subscribe you consent to pharmaphorum media occasionally sending you marketing emails in compliance with GDPR rules.




You can unsubscribe at any time by clicking the link in the footer of our emails. For information about our privacy practices, please visit our website.

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices.


Patients
Reverba podcast featuring CEO Cheryl Lubbert
Sponsored

Patient engagement throughout the product lifecycle

One of the things that makes patient engagement for pharma companies so challenging is that it's not something that can be added to one step of a process and then checked off the list.

R&D
6th Inflammasome Therapeutics Summit banner
Partner Content

6th Inflammasome Therapeutics Summit

In the rapidly evolving field of inflammasome therapeutics, the need for innovative approaches to overcome the preclinical and clinical hurdles is more critical than ever.